Ibaflin European Union - English - EMA (European Medicines Agency)

ibaflin

intervet international bv - ibafloxacin - antibacterials for systemic use - dogs; cats - dogs:ibaflin is indicated for the treatment of the following conditions in dogs:dermal infections (pyoderma - superficial and deep, wounds, abscesses) caused by susceptible strains of staphylococci, escherichia coli and proteus mirabilis;acute, uncomplicated urinary-tract infections, caused by susceptible strains of staphylococci, proteus species, enterobacter spp., e. coli and klebsiella spp.;respiratory-tract infections (upper tract) caused by susceptible strains of staphylococci, e. coli, and klebsiella spp.ibaflin gel is indicated in dogs for the treatment of the following conditions:dermal infections (pyoderma - superficial and deep, wounds, abscesses) caused by susceptible pathogens such as staphylococcus spp., e. coli and p. mirabilis.cats:ibaflin gel is indicated in cats for treatment of the following conditions:dermal infections (soft-tissue infections - wounds, abscesses) caused by susceptible pathogens such as staphylococcus spp., e. coli, proteus spp. and pasteurella spp.;upper respiratory-tract infections caused by susceptible pathogens such as staphylococcus spp., e. coli, klebsiella spp. and pasteurella spp.